Shan et al reported NAP1L1 as a regulator of cardiac fibrosis, particularly in ischemic cardiomyopathy, through inhibition of YAP1 ubiquitination and degradation in cardiac fibroblasts43. This evidence concerns the gene YAP1 and fibrosis.